Skip to main content
OpenTrials
Completed

NCT Number: NCT02691481

Diabetes-Specific Nutritional Formulas Versus Oatmeal

Diabetes-specific nutritional formulas (DSNFs) are frequently used as part of medical nutrition therapy for patients with type 2 diabetes in order to improve glycemic control and enhance weight reduction. The mechanism through which DSNFs improve postprandial (PP) plasma glucose is not yet known.

The aim of this study is to compare the effects of 2 DSNFs versus oatmeal on PP plasma glucose, serum insulin and serum active glucagon-like peptide-1 (GLP-1), serum free fatty acids (FFA) and serum triglycerides (TG).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with type 2 diabetes treated with oral diabetes medications

Exclusion criteria

  • Type 1 diabetes

Treatment and study plan

Oatmeal breakfast

Dietary Supplement

Glucerna formula

Dietary Supplement

Ultra Glucose Control formula

Dietary Supplement

Primary outcomes

  1. Glucose area under the curve 0-240 minutes

    Time frame: 240 minutes

Sponsors and collaborators

Lead sponsor

Joslin Diabetes Center

Other

Registry information

Official study title

Effect of Diabetes-specific Formulas on Glucose Metabolism and GLP-1 Secretion in Patients With Type 2 Diabetes

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Feb 25, 2016
Registry last updated
Feb 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.